MYIA
CLB icon

Mount Yale Investment Advisors’s Core Laboratories CLB Stock Holding History

Mount Yale Investment Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,846
Closed -$472K – 322
2019
Q1 		$472K Sell
6,846
-4,084
-37% -$274K 0.09% 184
2018
Q4 		$709K Sell
10,930
-3,686
-25% -$318K 0.14% 134
2018
Q3 		$1.29M Sell
14,616
-5,517
-27% -$622K 0.23% 96
2018
Q2 		$2.54M Buy
20,133
+97
+0.5% +$11.8K 0.48% 49
2018
Q1 		$2.17M Buy
+20,036
New +$2.22M 0.46% 54

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mount Yale Investment Advisors's CLB Position: Q2 2019 in Review

Mount Yale Investment Advisors sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 6,846 shares — an estimated $472K sold.

Mount Yale Investment Advisors first reported a position in CLB in Q1 2018 and held it in 5 quarters. The position peaked at $2.54M in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • Mount Yale Investment Advisors reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 6,846 Core Laboratories shares in Q2 2019, an estimated $472K.
  • Mount Yale Investment Advisors first reported a position in Core Laboratories in Q1 2018 and held it in 5 quarters.
  • Mount Yale Investment Advisors's Core Laboratories position peaked at $2.54M in Q2 2018.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.